ArticleJournal of gastrointestinal cancer2024

Exceptional Response to Pembrolizumab in HER2-Positive Gallbladder Carcinoma with High Tumor Mutational Burden.

Akinori Sasaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.